Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for Diversity Alliance for Science

SECAUCUS, N.J.--(BUSINESS WIRE)--Caligor Rx, a leader in the global procurement of comparator drugs for clinical trials worldwide, today announced that Managing Director Tammy Bishop has been elected to the Board of Directors for Diversity Alliance for Science (DA4S), a national organization that fosters supplier diversity within the life sciences industry.

"It is a privilege to join the board of DA4S, and I look forward to contributing my knowledge and experience to help the organization achieve its strategic objectives," said Bishop, whose term on the 16-member board runs through May 2017. "DA4S plays a vital role in championing the benefits of diversity within the life sciences community. I am eager to share the organization's mission with leading life sciences companies across New England."

"As the managing director of Caligor Rx, Tammy has demonstrated the strong, energetic and visionary leadership that supports DA4S's mission to broaden supplier diversity across the entire life sciences community, including businesses and academic and government institutions," said DA4S President Sylvester Wilkins. "Tammy 's more than 20 years of pharma industry experience and her unique entrepreneurial skills make her especially well suited to serve our board."

Prior to joining Caligor Rx in 2010, Bishop worked in senior-level business development positions at Pharmarama and IDIS Pharmaceuticals. In addition, she served in senior corporate communications positions at OXiGENE, Gemini Genomics and Indevus Pharmaceuticals. In 2011, she was selected as a protégé for the DA4S Mentor Program and was instrumental in shepherding Caligor Rx's national certification as a Woman-owned Business by the Women's Business Enterprise National Council.

Bishop is a member of the Drug Information Association, Healthcare Distribution Management Association, Healthcare Women's Business Association and Institute for Supply Chain Management. She received a Master's Degree in Business Administration from the Simmons College School of Management.

About Caligor Rx

Caligor Rx is an international pharmaceutical supply company engaged in efficient, cost-effective sourcing and supply of comparator drugs for clinical trials worldwide. Certified by the Women's Business Enterprise National Council as a Woman-Owned Business, Caligor Rx is licensed to distribute approved and unlicensed medicines in the continental United States and throughout Europe. With headquarters in Secaucus, New Jersey and Dartford, UK, the Company's operations include state-of-the-art warehousing and distribution, complete with monitored cold chain and ambient storage capabilities. Caligor Rx's retail pharmacy, founded in 1919, serves patients, physicians, hospitals and healthcare providers. Information about the company's services is available at www.caligorrx.com.

Contacts

Sharon Merrill Associates
Scott Solomon, 617-542-5300
Vice President
[email protected]

Suggested Articles

It’s been a minute, but AstraZeneca has gotten the FDA’s all-clear to restart the U.S. study of its COVID-19 vaccine.

Solid Bio is teaming up with Ultragenyx on Duchenne muscular dystrophy in a deal worth $40 million upfront but could net it another $255 million.

The RNAi therapy drove a 72% reduction in urinary oxalate from baseline, boosting Alnylam’s hopes of using the drug in a broad patient population.